As a continuation, we revealed the novel applicable therapy evidence, centrally, bypassing key activated specific collateral pathways, and BPC 157 effectiveness, g-ng, regimens, given topically at the swollen brain, intraperitoneally or intragastrically, as an early or delayed application
266 SchmidtEKTorres-EspinARaposoPJMadsenKLKigerlKAPopovichPGet al
At RegenMD, GHK-Cu is prescribed as a standalone injectable therapy
As our results showed, there is no difference between them in terms of efficacy, but in terms of patients tolerance, advantages, and disadvantages of each route, the sublingual route is preferred over IM and oral routes
It antagonizes the glutamate induced neurotoxicity and also manifests analgesic effects